TATDN2-SETD5 Fusion FISH Probe
The TATDN2-SETD5 Fusion FISH Probe is used to confirm a fusion of the TATDN2 and SETD5 genes. The fusion of the TATDN2 and SETD5 genes has been associated with Kidney Renal Clear Cell Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TATDN2-SETD5-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TATDN2-SETD5-20-AQAQ | 20 (40 μL) | 200 μL |
|
TATDN2 Gene Summary
The TatD DNase Domain Containing 2 (TATDN2) gene is located on chr3 :10290176-10322906 at 3p25.3.
Gene Name: TatD DNase Domain Containing 2
Chromosome: CHR3: 10290176 -10322906
Locus: 3p25.3
SETD5 Gene Summary
This function of this gene has yet to be determined but based on sequence similarity to other SET domain proteins it may function as a histone methyltransferase. Mutations in this gene have been associated with an autosomal dominant form of intellectual disability. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2017]
Gene Name: SET Domain Containing 5
Chromosome: CHR3: 9439402 -9519838
Locus: 3p25.3
Gene Diseases
The TATDN2 SETD5 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Kidney Renal Clear Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|